Policy / Regulatory

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

The National Medical Products Administration (NMPA) has released the 110th batch of the Catalog of Reference Listed Drugs (RLD) for Chemical Generic Drugs, adding 28 new drug specifications and providing…

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
NHSA Implements Region-Based Pricing System for Medical Services
NHSA (prev. SMIA)

NHSA Implements Region-Based Pricing System for Medical Services

Beijing Tightens Price Risk Management for Scarce Medications

Beijing Tightens Price Risk Management for Scarce Medications

NMPA's CDE Reports 4,900 Clinical Trial Filings for Innovative Drugs in 2024
CDENMPA

NMPA’s CDE Reports 4,900 Clinical Trial Filings for Innovative Drugs in 2024

CDE Issues New Requirements for IND Applications of Innovative Drugs
CDENMPA

CDE Issues New Requirements for IND Applications of Innovative Drugs

Show More